The CLIP1–LTK fusion is an oncogenic driver in non‐small‐cell lung cancer-Reference-Cited by-同舟云学术

The CLIP1–LTK fusion is an oncogenic driver in non‐small‐cell lung cancer

Published:2021-11-24 Issue:7888 Volume:600 Page:319-323
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

Izumi Hiroki,Matsumoto Shingo,Liu Jie,Tanaka Kosuke,Mori Shunta,Hayashi Kumiko,Kumagai Shogo,Shibata Yuji,Hayashida Takuma,Watanabe Kana,Fukuhara Tatsuro^ORCID,Ikeda Takaya,Yoh Kiyotaka,Kato Terufumi,Nishino Kazumi,Nakamura Atsushi,Nakachi Ichiro,Kuyama Shoichi,Furuya Naoki^ORCID,Sakakibara-Konishi Jun,Okamoto Isamu,Taima Kageaki,Ebi Noriyuki,Daga Haruko,Yamasaki Akira,Kodani Masahiro,Udagawa Hibiki,Kirita Keisuke,Zenke Yoshitaka,Nosaki Kaname,Sugiyama Eri,Sakai Tetsuya,Nakai Tokiko,Ishii Genichiro,Niho Seiji,Ohtsu Atsushi,Kobayashi Susumu S.^ORCID,Goto Koichi^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

https://www.nature.com/articles/s41586-021-04135-5.pdf

Reference31 articles.

1. Konig, D., Savic Prince, S. & Rothschild, S. I. Targeted therapy in advanced and metastatic non-small cell lung cancer. An update on treatment of the most important actionable oncogenic driver alterations. Cancers 13, 713 (2021).

2. Saito, M. et al. Gene aberrations for precision medicine against lung adenocarcinoma. Cancer Sci. 107, 713–720 (2016).

3. The Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature 511, 543–550 (2014).

4. Fernandez-Cuesta, L. et al. CD74–NRG1 fusions in lung adenocarcinoma. Cancer Discov. 4, 415–422 (2014).

5. Non-small cell lung cancer version 4.2021 National Comprehensive Cancer Network https://www.nccn.org/professionals/physician_gls/pdf/nscl.pdf (2021).

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multi-Omics Analysis of Primary Prostate Cancer Datasets Reveals Novel Biomarkers;Biochemical Genetics;2024-08-07

2. Current status of molecular diagnostics for lung cancer;Exploration of Targeted Anti-tumor Therapy;2024-06-27

3. Establishment and characterization of novel high mucus-producing lung tumoroids derived from a patient with pulmonary solid adenocarcinoma;Human Cell;2024-04-17

4. RAF1 gene fusions are recurrent driver events in infantile fibrosarcoma‐like mesenchymal tumors;The Journal of Pathology;2024-04-17

5. LTK mutations responsible for resistance to lorlatinib in non-small cell lung cancer harboring CLIP1-LTK fusion;Communications Biology;2024-04-04